Author:
Uduagbamen Peter K.,Bamikefa Titilope A.,Oyelese Adesola T.,O Shitu Abdul-Karim,Ano-Edward Gbemi H.,Adeleke Adeola A.,Odafen Oseiga P,Siden David O.,Tijani Oluwadamilola E.,Iwuh Divine-Michael,Adebanwi Princess T.
Reference38 articles.
1. Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: A 21st-century challenge in global health. Nephron Clin Pract. 2011;118(3):c269-77. doi:10.1159/000321382
2. Kovesdy CP. Epidemiology of chronic kidney disease: An update 2022. Kidney Int Suppl (2011). 2022;12(1):7-11. doi:10.1016/j.kisu.2021.11.003
3. Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765
4. Maranduca MA, Clim A, Pinzariu AC, Statescu C, Sascau RA, Tanase DM, et al. Role of arterial hypertension and angiotensin II in chronic kidney disease (Review). Exp Ther Med. 2023;25(4):153. doi:10.3892/etm.2023.11852
5. Fang YQ, He DF, Yang CM, Wang XK, Zeng CY, Wang HY, et al. Effects of lipid-modulation and antiplatelet treatment on the endothelial lipase expression. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010;22(11):663-5.